Authors:
Jan Zeevaart NECSA Department of Radiochemistry PO Box 582 Pretoria 0001 South Africa

Search for other papers by Jan Zeevaart in
Current site
Google Scholar
PubMed
Close
,
Judith Wagener NECSA Department of Radiochemistry PO Box 582 Pretoria 0001 South Africa

Search for other papers by Judith Wagener in
Current site
Google Scholar
PubMed
Close
,
Maria Neves Instituto Tecnologico Nuclear 2686-953 Sacavem Portugal

Search for other papers by Maria Neves in
Current site
Google Scholar
PubMed
Close
,
Maria Costa Instituto Nacional de Engenharia, Tecnologia e Inovação, I.P. 1649-038 Lisbon Portugal

Search for other papers by Maria Costa in
Current site
Google Scholar
PubMed
Close
,
Cristina Rodrigues Instituto Nacional de Engenharia, Tecnologia e Inovação, I.P. 1649-038 Lisbon Portugal

Search for other papers by Cristina Rodrigues in
Current site
Google Scholar
PubMed
Close
,
Mildred Dithebe North West University, Mafikeng Campus CARST Mmabatho 2735 South Africa

Search for other papers by Mildred Dithebe in
Current site
Google Scholar
PubMed
Close
,
Elmaré Kilian University of Pretoria UPBRC, Onderstepoort Pretoria 0002 South Africa

Search for other papers by Elmaré Kilian in
Current site
Google Scholar
PubMed
Close
, and
Ignacy Cukrowski University of Pretoria Department of Chemistry Pretoria 0002 South Africa

Search for other papers by Ignacy Cukrowski in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

99mTc-DMSA (dimercaptosuccinic acid) is known to be a safe and effective agent for static renal imaging. However, it has a long uptake time which is a limiting factor in diagnostic procedures and also leads to a relatively high radiation dose being administered to patients. There is a constant search for possible new renal imaging agents with a good resolution, kidney/liver contrast and low radiation dose to all organs. A series of biguanide derivatives (potential as non-insulin-dependent diabetes mellitus agents) labelled with 99mTc were investigated as potential alternative kidney-imaging agents on theoretical grounds (in silico) and their biodistribution (in vivo) verified in a limited number of animal experiments. Such a dual approach has the benefit that it reduces the number of animal experiments needed to evaluate a potential radiopharmaceutical. The blood plasma model shows little or no complexation of the biguanide type ligands by the metal ions in blood plasma. It was therefore expected that these ligands will clear rapidly through the kidneys and liver (increased lipophilicity). These predictions were verified by studies on single vervets comparing them with 99mTc-DMSA as gold standard. All the biguanide derivatives labelled with 99mTc show liver, kidney and gallbladder uptake in vervets. It was shown that the agent 99mTc-CBIG (carboxylbiguanide) has a very fast kidney clearance, which will reduce the dose to organs (as experienced for 99mTc-DMSA), although it’s potential as a kidney agent is limited by its gallbladder uptake.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)